MedTrace Logo

CALM: Managing Distress in Malignant Brain Cancer

NCT06180460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-08

No results posted yet for this study

Summary

The purpose of this study is to test an empirically supported psychotherapeutic intervention, Managing Cancer and Living Meaningfully (CALM), compared to treatment as usual (TAU) in those with malignant brain cancer diagnoses.

Conditions

Interventions

BEHAVIORAL

CALM

The CALM intervention is a supportive-expressive therapy that is administered by CALM trained clinicians in a particular style.

BEHAVIORAL

Treatment as usual

Treatment as usual includes a list of local / national resources (e.g., psychologist, social worker, or other mental health providers) if an individual chooses to seek treatment for the distress they are experiencing.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Ashlee Loughan, Ph.D · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180460 on ClinicalTrials.gov